IGF-1 as a Drug for Preterm Infants: A Step-Wise Clinical Development.

about

The genetics of retinopathy of prematurity: a model for neovascular retinal disease

P2860

Q57165717-907659BC-CCB1-4721-A6A8-DB0A37EA3267

P2860

IGF-1 as a Drug for Preterm Infants: A Step-Wise Clinical Development.

Item

http://www.wikidata.org/entity/Q47568034

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

IGF-1 as a Drug for Preterm Infants: A Step-Wise Clinical Development.

@en

IGF-1 as a Drug for Preterm Infants: A Step-Wise Clinical Development.

@nl

type

Item

label

IGF-1 as a Drug for Preterm Infants: A Step-Wise Clinical Development.

@en

IGF-1 as a Drug for Preterm Infants: A Step-Wise Clinical Development.

@nl

prefLabel

IGF-1 as a Drug for Preterm Infants: A Step-Wise Clinical Development.

@en

IGF-1 as a Drug for Preterm Infants: A Step-Wise Clinical Development.

@nl

P1476

IGF-1 as a Drug for Preterm Infants: A Step-Wise Clinical Development

@en

P2093

Ann Hellstrom

http://www.w3.org/2001/XMLSchema#string

Anna-Lena Hard

http://www.w3.org/2001/XMLSchema#string

Chatarina Lofqvist

http://www.w3.org/2001/XMLSchema#string

David Ley

http://www.w3.org/2001/XMLSchema#string

Ingrid Hansen-Pupp

http://www.w3.org/2001/XMLSchema#string

Jan Borg

http://www.w3.org/2001/XMLSchema#string

Lois E H Smith

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

IGF-I in the clinics: Use in retinopathy of prematurity

Insulin-like growth factor 1 has multisystem effects on foetal and preterm infant development

Mecasermin rinfabate: rhIGF-I/rhIGFBP-3 complex: iPLEX

Longitudinal infusion of a complex of insulin-like growth factor-I and IGF-binding protein-3 in five preterm infants: pharmacokinetics and short-term safety

Unlicensed and off label drug use in neonates

A pharmacokinetic and dosing study of intravenous insulin-like growth factor-I and IGF-binding protein-3 complex to preterm infants

IGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth.

Open-label trial of recombinant human insulin-like growth factor 1/recombinant human insulin-like growth factor binding protein 3 in myotonic dystrophy type 1.

Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1.

Expanding the mind: insulin-like growth factor I and brain development.

P304

5964-5970

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/1381612823666171002114545

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Luca A. Ramenghi

Boubou Hallberg

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28969546

http://www.w3.org/2001/XMLSchema#string

P921

peptide

blood proteins

preterm infant

biomedical investigative technique

hemic and immune systems

fluids and secretions

P932

5824464

http://www.w3.org/2001/XMLSchema#string

IGF-1 as a Drug for Preterm Infants: A Step-Wise Clinical Development.

about

P2860

P2860

IGF-1 as a Drug for Preterm Infants: A Step-Wise Clinical Development.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932